how many people are using glp-1 Antagonists Increase Plan Drug Spend - What's Next how many people use glp
Description
McCallum, R
At the same time, many of these benefits appear to be driven by broader improvements in weight and metabolic health, not just the medication itself
During hyperglycemia, GIP potentiates glucose-induced insulin secretion without exhibiting a glucagonotropic effect (35)
Inclusion and exclusion criteria, as well as methods for treatment, have been described (58)
Side Effects Both medications share similar side effect profiles: Nausea (usually mild and temporary) Diarrhea or constipation Decreased appetite Fatigue during initial weeks Tirzepatide may cause slightly more gastrointestinal effects initially due to its dual-action mechanism, but most patients adapt within 2-4 weeks
Unlocking reimbursement Perhaps the greatest challenge for AOM contenders is to unlock access and reimbursement
